Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

8
Depositories share info of firms with bourses on FDI limit

2018-06-18 freepressjournal.in
A red flag has been activated in HDFC Bank, Wonderla Holidays, IndusInd Bank, Ashapura Minechem, Cyient and S H Kelkar & Company,
ABBOTINDIA JVLAGRO INDUSINDBK 538268 519248 532187 ASHAPURMIN 527001 HDB 500180 HDFCBANK 500488 WONDERLA

8
Depositories share cos#39; info with exchanges on FDI limits

2018-06-17 moneycontrol
Depositories have shared information about activation of red flag and FDI limit breach related to 12 companies, including HDFC Bank, with the BSE and the NSE, according to notices. As per the separate notices issued by the two bourses, a red flag has been activated in HDFC Bank, Wonderla Holidays, IndusInd Bank, Ashapura Minechem, Cyient Ltd and S H Kelkar and Company.
ABBOTINDIA JVLAGRO INDUSINDBK 538268 519248 532187 ASHAPURMIN 527001 HDB 500180 HDFCBANK 500488 WONDERLA

8
Depositories share info on activation of red flag, breach of FDI limit with bourses

2018-06-17 thehindubusinessline
(PTI) Depositories have shared information about activation of red flag and breach of FDI limit related to 12 companies, including HDFC Bank, with the BSE and the NSE.
ABBOTINDIA ALNSE JVLAGRO INDUSINDBK 538268 519248 532187 ASHAPURMIN 527001 HDB 500180 HDFCBANK 500488 WONDERLA

0
Merck shares hit record high after profit jump

2018-04-30 thehindubusinessline
The Merck logo is seen at an office building in Singapore in this file photo. - Reuters
ABBOTINDIA 500488

0
Corona Remedies acquires two brands from Abbott

2018-04-02 moneycontrol
City-based pharma firm Corona Remedies today announced the acquisition of Obimet and Thyrocab brands, comprising of 14 product line extensions, from Abbott India.
ABBOTINDIA 500488

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...